Yet Inflation, Rising Debt and Trade Tensions Remain Top Concerns for 2025ISELIN, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, released the results of its 2025 Economic Outlook survey showcasing widespread optimism and confidence from 1,000 business owners and leaders on both the U.S. economic landscape and within their own companies. Specifically, businesses are increasing capital spending, investing in technology (specifically AI), and pointing ...

Core Points - Provident Bank awarded a total of $50,000 in grants to 11 small businesses and 4 non-profit organizations through the FHLBNY Small Business Recovery Grant Program [1] - The SBRG program provides grants of up to $10,000 to qualifying small businesses facing economic challenges due to various factors [1][2] - The initiative aims to support the financial well-being of local establishments and enhance their ability to serve customers [2] Company Overview - Provident Bank, founded in 1839, is the oldest community-focused financial institution in New Jersey and a wholly owned subsidiary of Provident Financial Services, Inc. [4] - As of September 30, 2024, Provident Bank has assets totaling $24.04 billion and operates 140 branches across New Jersey and parts of New York and Pennsylvania [4] - The bank offers a range of financial solutions, including fiduciary and wealth management services through its subsidiary, Beacon Trust Company [4]

Vabysmo PFS is the first and only prefilled syringe containing a bispecific antibody, offering a convenient alternative to currently available Vabysmo vialsVabysmo has demonstrated rapid and robust vision and anatomical improvements in neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME) and retinal vein occlusion (RVO)The ready-to-use Vabysmo PFS is co-packaged with the only CE-marked needle specifically designed for intravitreal injection Basel, 13 December 2024– Roche (SIX: R ...

Laurentian Research is a resource industry veteran with a Ph.D. in geoscience and decades of investment experience. He leads the investing group The Natural Resources Hub, with an aim of helping membes uncover undervalued opportunities in the energy and mining sectors with multi-bagger potential. He is also passionate about helping members find dividend growth opportunities from long-term growth industries. Members get weekly newsletters, proprietary in-depth analyses, trade alerts, model portfolios, privat ...

- Inupadenant + carboplatin/pemetrexed in Phase 2 A2A-005 trial demonstrated a 63.9% overall response rate (ORR) and a median PFS of 7.7 months for all evaluable patients across the cohorts- Recommended Phase 2 dose (RP2D) of inupadenant 80mg + carboplatin/pemetrexed demonstrated 73.3% ORR, with 64.6% of patients achieving landmark 6-month PFS- Inupadenant + carboplatin/pemetrexed safety profile was manageable and tolerable, with no dose-dependent toxicity observed- Inupadenant deprioritized to focus resour ...

ENDEAVOUR ANNOUNCES POSITIVE PFS RESULTS FOR ASSAFOU PROJECT IN CÔTE D’IVOIRE $1,526m NPV(5%) and IRR of 28% at $2,000/oz • 329kozpa at AISC of $892/oz over first 10 years HIGHLIGHTS: PFS confirms Assafou's potential to become a tier 1 asset for EndeavourPFS highlights 329kozpa production at AISC of $892/oz over first 10 years: 15-year mine life based on maiden reserve of 4.1Moz Robust project economics with after-tax NPV(5%) of $1,526m and IRR of 28%, at a $2,000/oz gold priceInitial capital of $734m bas ...

ISELIN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, is pleased to announce that Kim Strignile has joined the Human Resources team as Senior Vice President, HR Business Partner Director. Ms. Strignile will lead the bank’s HR Business Partner and Talent Acquisition teams, playing a pivotal role in driving its people strategy. In addition, Ms. Strignile will serve as a trusted advisor and change agent, collaborating closely with Provident’s leaders ...

-- 27% relative risk reduction of progression or death with GRANITE vs. control in all treated population (HR=0.73 [90% CI, 0.44, 1.21]) -- -- 50% relative risk reduction of progression or death with GRANITE vs. control in low ctDNA subgroup (HR=0.50 [90% CI, 0.20-1.28]) -- -- Progressing through court-administered financial restructuring process with continued interest from multiple parties  EMERYVILLE, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (OTC: GRTSQ), a clinical-stage biotechnolo ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-31566 PROVIDENT FINANCIAL SERVICES, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 42-1547151 (State or Other Ju ...

Provident Financial Services, Inc. Reports Third Quarter Earnings and Declares Quarterly Cash Dividend ISELIN, NJ, October 29, 2024 - Provident Financial Services, Inc. (NYSE:PFS) (the "Company") reported net income of $46.4 million, or $0.36 per basic and diluted share for the three months ended September 30, 2024, compared to a net loss of $11.5 million, or $0.11 per basic and diluted share, for the three months ended June 30, 2024 and net income of $28.5 million, or $0.38 per basic and diluted share, for ...